Moser Wealth Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Moser Wealth Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.69K	Hold	200	–	–	﹤0.01%	189
2025 Q1	$1.61K	Hold	200	–	–	﹤0.01%	153
2024 Q4	$1.8K	Hold	200	–	–	﹤0.01%	133
2024 Q3	$1.47K	Hold	200	–	–	﹤0.01%	135
2024 Q2	$1.14K	Hold	200	–	–	﹤0.01%	146
2024 Q1	$1K	Hold	200	–	–	﹤0.01%	145
2023 Q4	$1.8K	Hold	200	–	–	﹤0.01%	135
2023 Q3	$1.55K	Hold	200	–	–	﹤0.01%	128
2023 Q2	$1.94K	Buy	+200	New	+$2.08K	﹤0.01%	123
2022 Q4	$864	Hold	200	–	–	﹤0.01%	122
2022 Q3	$2K	Hold	200	–	–	﹤0.01%	132
2022 Q2	$2K	Hold	200	–	–	﹤0.01%	125
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	129
2021 Q4	$5K	Buy	+200	New	+$4.74K	﹤0.01%	125

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moser Wealth Advisors's AUPH Position: Q2 2025 in Review

Moser Wealth Advisors held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2025 at 200 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #189.

Moser Wealth Advisors first reported a position in AUPH in Q4 2021 and has held it in 14 quarters since. The position peaked at $5K in Q4 2021. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

Moser Wealth Advisors held 200 shares of Aurinia Pharmaceuticals worth $1.69K as of Q2 2025.
Moser Wealth Advisors left its Aurinia Pharmaceuticals share count unchanged in Q2 2025.
Aurinia Pharmaceuticals made up ﹤0.01% of Moser Wealth Advisors's portfolio in Q2 2025, its #189 holding.
Moser Wealth Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
Moser Wealth Advisors's Aurinia Pharmaceuticals position peaked at $5K in Q4 2021.
219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on Moser Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.